Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02183909 · ClinicalTrials.gov registry record · NA

Connecting Resources for Urban Sexual Health

A NA study of HIV and Sexually Transmitted Infections, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
378
Enrollment target
1
Study location

NCT02183909: Completed NA study of HIV and Sexually Transmitted Infections, sponsored by University of California, San Francisco.

NCT02183909 is a NA study of HIV and Sexually Transmitted Infections that has completed, run by University of California, San Francisco. The registered enrollment target is 378 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02183909, a NA study of HIV and Sexually Transmitted Infections, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
378 participants
Enrollment target
1
Study location

Study Summary

The overall goal of the CRUSH project is to enhance and extend a response to the local HIV/AIDS epidemic in Alameda County with a set of innovative, evidence-based interventions across the continuum of HIV prevention and care, targeting individuals and communities most vulnerable to HIV. The East Bay AIDS Center, in partnership with the University of California San Francisco's Center for AIDS Prevention Studies, the Gladstone Institutes, and several key community-based organizations, are engaging in a participatory partnership to enhance and implement HIV services which target the East Bay's highest risk population- young men who have sex with men (Y/MSM). Specifically, the CRUSH Project is designed to evaluate a combination of program approaches to address the sexual health care needs of young gay men of color and their sexual partners by enhancing the current program activities of the Downtown Youth Clinic (DYC). We hypothesize that we can reduce the impact of HIV among Y/MSM by expanding the current DYC services structure in two ways. We intend to expand HIV testing, and linkage to and retention in care for youth who test HIV positive, providing them with intensive risk-reduction counseling and antiretroviral treatment, and thereby ultimately reducing the risk of further HIV transmission. And we intend for the first time to offer a comprehensive combination package of preventive services to HIV-negative youth, including routine accesses to HIV/STI screening and treatment, and access to HIV pre-exposure prophylaxis (PrEP). The CRUSH Project will also have a substudy that will enroll HIV-negative participants who are eligible to receive PEP. The substudy will evaluate the tolerability and acceptability of a 28 day course of Stribild® given as post-exposure prophylaxis (PEP) to prevent sexual acquisition of HIV-1 in Y/MSM of color.

Primary Outcome

Expanding the investigators currently successful HIV testing strategy-collaborations and systems of referral of new cases of HIV from existing partners-so that referrals are also received for high risk negatives to receive sexual health services. Implementing two new strategies: social network testing and a youth outreach corps working with partner agencies; it is hypothesized that social network testing will increase the proportion of positive test results.

Interventions

  • OTHER Testing and linkage to care for Y/MSM
  • BEHAVIORAL Engagement and retention for HIV-positive Y/MSM in care
  • OTHER Engagement and retention for HIV-negative Y/MSM in sexual health services
  • DRUG Stribild PEP Substudy

Study Locations (1)

California

  • Downtown Youth Clinic - Oakland

Trial Details

FieldValue
Enrollment Target 378 participants
Start Date 2013-05
Est. Completion 2017-08
Phase NA

What the finished NCT02183909 record still lists

NCT02183909 is an interventional study that assigns participants to a tested intervention. The registered 378 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (14% lower).

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 4 interventions - of which Testing and linkage to care for Y/MSM is the first listed.

NCT02183909 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02183909 about?

NCT02183909 is a clinical study titled "Connecting Resources for Urban Sexual Health". The overall goal of the CRUSH project is to enhance and extend a response to the local HIV/AIDS epidemic in Alameda County with a set of innovative, evidence-based interventions across the continuum of HIV prevention and care, targeting individuals and communities most vulnerable to HIV. The East Ba...

What is the current status of trial NCT02183909?

This trial is currently completed. It is a NA study. The enrollment target is 378 participants. The study started on 2013-05. Estimated completion is 2017-08.

What conditions does trial NCT02183909 study?

This clinical trial studies the following conditions: HIV, Sexually Transmitted Infections.

What interventions are being tested in trial NCT02183909?

The interventions under investigation include: Testing and linkage to care for Y/MSM (OTHER), Engagement and retention for HIV-positive Y/MSM in care (BEHAVIORAL), Engagement and retention for HIV-negative Y/MSM in sexual health services (OTHER), Stribild PEP Substudy (DRUG).

Who is sponsoring clinical trial NCT02183909?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02183909 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02183909's enrollment target sits among peer trials

378 52nd of 303 higher than 252 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04254185 · 378 participants · NA

    Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow

  • NCT06616584 · 378 participants · Phase 2

    Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • NCT07024784 · 377 participants · Phase 2

    A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

  • NCT04560673 · 380 participants · Phase 2

    Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02183909, the US trial registry maintained by the National Library of Medicine. NCT02183909 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.